Insilico's AI-designed drug rentosertib shows 2.7–3.5 year biological age reversal
HealthcareAIGuy · x · 2026-09-08
Rentosertib, an AI-designed drug from Insilico Medicine, is showing early signs it could slow biological aging: patients appeared biologically younger across all 6 aging clocks tested, with one clock showing a 2.7–3.5 year reversal.
- It's an early signal that an AI-designed drug may have anti-aging effects in human trials
- The poster expects progress in this direction to only accelerate
Related event: AI-Designed IPF Drug Rentosertib Shows Biological Age Reversal in Trial(18 posts)→
More from Apps
- Higgsfield Launches Playable: One-Prompt Playable Ads — CurieuxExplorer · 2026-10-27
- Google Docs and Drive add native Markdown support for human-AI collaboration — thisiskp_ · 2026-10-27
- Instinct launches Link balance to let agents spend within set budgets — jeff_weinstein · 2026-10-27
- Open Dungeon Master: open-source AI Dungeon Master app hits Play Store, runs 5e on a 16GB GPU — lebbi · 2026-10-27
- Show HN: Wraps, open-source Resend-style email API running on your own AWS SES — stewartjarod · 2026-10-27
- Sentry CEO builds AI-generated entity pages for whisky brands in side project Peated — zeeg · 2026-10-27